Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences Market Cap : 2.350B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 187.84B |
| Eli Lilly & Co. | 952.34B |
| Merck & Co., Inc. | 303.45B |
| Madrigal Pharmaceuticals, Inc. | 9.880B |
| Janux Therapeutics, Inc. | 786.73M |
Market Cap Related Metrics
| PS Ratio | 7.974 |
| PEG Ratio | -0.6302 |
| Price to Book Value | 5.389 |
| Price | 18.99 |
| Earnings Yield | -18.07% |
| PEGY Ratio | -0.6302 |